Madam Chair, there must be diagnosis and treatment of CCSVI and then we can follow the people with the research.
I also want to point out that it is simply not fair or consistent with charter values to say that angioplasty correction of diagnosed venous insufficiency will be available to Canadians generally but not to people who happen also to be diagnosed with MS. It is not fair or consistent with charter values to deprive people, even if the diagnosis is venous insufficiency, for no other reason but they are diagnosed with MS.
It is also not an efficient use of federal money to deny to MS sufferers a treatment which is not only cheap, about a quarter of the yearly cost of maintaining the disease, but by several accounts, actually appears to do good.